Skip to content

Cerus CERS Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Haemonetics logo
HaemoneticsHAE
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's software and technology licenses, net?
Cerus (CERS) reported software and technology licenses, net of $11.2M in Q1 2026.
How has Cerus's software and technology licenses, net changed year-over-year?
Cerus's software and technology licenses, net decreased by 2.8% year-over-year, from $11.52M to $11.2M.
What is the long-term trend for Cerus's software and technology licenses, net?
Over 5 years (2020 to 2025), Cerus's software and technology licenses, net has grown at a 8.4% compound annual growth rate (CAGR), from $7.37M to $11.05M.